Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDOruka Therapeutics Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 3 | -$0.64 | -$0.38 | -$0.50 |
| Q2 2025 | 1 | -$0.54 | -$0.54 | -$0.54 |
| Q3 2025 | 1 | -$0.57 | -$0.57 | -$0.57 |
| Q4 2025 | 1 | -$0.60 | -$0.60 | -$0.60 |
| Q1 2026 | 1 | -$0.52 | -$0.52 | -$0.52 |
| Q2 2026 | 1 | -$0.55 | -$0.55 | -$0.55 |
| Q3 2026 | 1 | -$0.58 | -$0.58 | -$0.58 |
| Q4 2026 | 1 | -$0.61 | -$0.61 | -$0.61 |
| Q1 2027 | 1 | -$0.54 | -$0.54 | -$0.54 |
| Q2 2027 | 1 | -$0.59 | -$0.59 | -$0.59 |
| Q3 2027 | 1 | -$0.64 | -$0.64 | -$0.64 |
| Q4 2027 | 1 | -$0.70 | -$0.70 | -$0.70 |
Oruka Therapeutics Inc. Earnings Date And Information
Oruka Therapeutics Inc. last posted its earnings results on Thursday, March 6th, 2025. The company reported $-0.49 earnings per share for the quarter, topping analysts' consensus estimates of $-0.68 by $0.19. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Oruka Therapeutics Inc. has generated $-5 earnings per share over the last year ($-4.99 diluted earnings per share) and currently has a price-to-earnings ratio of -8.22. Oruka Therapeutics Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, January 30th, 2025 based on prior year's report dates.
Oruka Therapeutics Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 12/30/2024 | Q4 2024 | N/A | -$0.64 | N/A | $0 | $0 |
| 09/30/2024 | Q3 2024 | N/A | -$1.91 | N/A | N/A | $0 |
| 06/30/2024 | Q2 2024 | N/A | -$0.76 | N/A | N/A | $0 |
| 03/30/2024 | Q1 2024 | N/A | -$1.66 | N/A | N/A | $0 |
| 12/30/2023 | Q4 2023 | N/A | -$0.90 | N/A | N/A | $0 |
| 09/29/2023 | Q3 2023 | N/A | -$1.19 | N/A | N/A | $0 |
| 06/29/2023 | Q2 2023 | N/A | -$1.23 | N/A | N/A | $0 |
| 03/30/2023 | Q1 2023 | N/A | -$1.12 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Oruka Therapeutics Inc. Earnings: FAQ's
Oruka Therapeutics Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, January 30th, 2025 based offlast year's report dates.
In the previous quarter, Oruka Therapeutics Inc. (:ORKA) reported $-0.49 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.68 by $0.19.
The conference call for Oruka Therapeutics Inc.'s latest earnings report can be listened to online.
The conference call transcript for Oruka Therapeutics Inc.'s latest earnings report can be read online.
Oruka Therapeutics Inc. (:ORKA) has a recorded net income of $-83,724,000.Oruka Therapeutics Inc. has generated $-4.99 earnings per share over the last four quarters.
Oruka Therapeutics Inc. (:ORKA) has a price-to-earnings ratio of -8.22 and price/earnings-to-growth ratio is -1.65.